Jenna Davidner
Stock Analyst at Barclays
(1.01)
# 3,928
Out of 5,078 analysts
30
Total ratings
36.4%
Success rate
-3.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COLL Collegium Pharmaceutical | Reiterated: Buy | $48 | $22.96 | +109.06% | 8 | Oct 15, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $110 | $68.20 | +61.29% | 8 | Oct 9, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $12 → $14 | $10.20 | +37.25% | 5 | Oct 6, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $25 | $36.42 | -31.36% | 5 | Aug 17, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $18 → $14 | $5.74 | +143.90% | 4 | Aug 17, 2026 |
Collegium Pharmaceutical
Oct 15, 2026
Reiterated: Buy
Price Target: $48
Current: $22.96
Upside: +109.06%
Tarsus Pharmaceuticals
Oct 9, 2026
Reiterated: Buy
Price Target: $110
Current: $68.20
Upside: +61.29%
Xeris Biopharma Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $10.20
Upside: +37.25%
Pacira BioSciences
Aug 17, 2026
Reiterated: Hold
Price Target: $25
Current: $36.42
Upside: -31.36%
Phathom Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $14
Current: $5.74
Upside: +143.90%